Physician profile
Jonathan Lee Lin
NPI 1083970156
$442.50
in general payments reported to CMS, 2019-2025
12 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.30 · 2021: $19.47 · 2022: $155 · 2023: $29.67 · 2024: $106 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $100.30 | 2022-2025 | Jardiance, Zepbound, Mounjaro |
| W. L. Gore & Associates, INC. | $98.84 | 2022 | |
| Abbvie INC. | $54.25 | 2024-2025 | |
| Amgen INC. | $31.40 | 2023-2024 | Repatha, Otezla |
| Abbott Laboratories | $28.57 | 2022 | |
| Exact Sciences Corporation | $23.97 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $22.06 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.93 | 2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $19.47 | 2021 | |
| Inspire Medical Systems, INC. | $17.22 | 2025 | Inspire |
| Novo Nordisk INC | $13.19 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.